Medtronic sees no harm from new inversion rules; stock gains 2% — 5 takeaways

Medtronic said the U.S. Treasury Department’s temporary and proposed rules on tax inversions won’t have a material financial impact based on the company’s preliminary review, according to the Sonoran Weekly Review.

Advertisement

Here are five takeaways:

 

1. Tax inversions are strategies used by companies to slash their tax bills by resettling their companies’ headquarters overseas.

 

2. After completing its acquisition of Covidien in January 2015, Medtronic moved headquarters overseas to Ireland in what appeared to be a tax inversion strategy.

 

3. In the past, President Obama has criticized device companies moving headquarters overseas to achieve lower tax rates.

 

4. Medtronic will continue to more fully examine the regulations and will provide appropriate disclosure concerning any potential material impact on the company.

 

5. The company’s stock is up 2.38 percent after the news, hitting $77.29 per share.

 

More articles on devices and implants:
Tyber Medical receives $362k loan from Pennsylvania state authority: 4 things to know
Device allows patients with tetraplegia to use laptop with their eyes: 3 takeaways
TranS1 appoints Brandon Arthurs as new VP of research & development: 4 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.